Skip to main content

Advertisement

Table 2 Clinical outcomes of patients with spontaneous bacterial peritonitis (SBP) due to Escherichia coli and Klebsiella species (EK), according to the production of extended-spectrum β-lactamase (ESBL)

From: Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellaspecies: A retrospective matched case-control study

Outcomes SBP due to P-value
  ESBL-EK (n = 26) Non-ESBL-EK (n = 78)  
Initial response    
   Complete response (n, %) 2 (8%) 28 (36%) < 0.001
   Treatment failure (n, %) 15 (58%) 10 (13%) 0.006
7-day mortality (n, %) 9 (35%) 3 (4%) < 0.001
30-day mortality (n, %) 12 (46%) 11 (14%) 0.001
  1. Initial response was assessed 72 hours after the initiation of empirical treatment